CoverageForm 410-K10-Q8-K13D13G13F

OXSQ · Oxford Square Capital Corp. - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · OXSQ

Income Statement

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Revenue----------
Cost of Revenue----------
Gross Profit----------
R&D----------
SG&A$312.7K-$357.8K$360.1K$355.3K-$395.3K$447.5K$346.6K-
Total Operating Expenses$4.79M-$4.68M$4.02M$4.06M-$4.15M$3.72M$3.81M-
D&A----------
Operating Income----------
Interest Expense$2.79M-$2.56M$1.93M$1.96M---$1.96M-
Income Tax----------
Net Income($25.52M)-($2.09M)$4.39M($8.12M)-($874.5K)$5.26M($1.77M)-
EPS - Basic$0.05-$0.07$0.08$0.09-$0.10$0.13$0.11-
EPS - Diluted$0.05-$0.07$0.08$0.09-$0.10$0.13$0.11-

Balance Sheet

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Cash & Equivalents$40.92M$51.93M$50.79M$29.79M$37.25M$34.93M$43.19M$30.01M$20.91M$5.74M
Accounts Receivable----------
Inventory----------
Accounts Payable----------
Current Assets----------
Total Assets$278.86M$306.74M$314.74M$274.85M$285.49M$299.73M$312.92M$290.18M$275.29M$277.67M
Current Liabilities----------
Long-term Debt---------$127.47M
Total Liabilities$155.59M$161.33M$155.78M$117.42M$136.61M$139.07M$153.45M$137.77M$130.95M$126.36M
Stockholders' Equity$123.27M$145.40M$158.96M$157.42M$148.88M$160.67M$159.47M$152.41M$144.34M$151.31M
Retained Earnings($413.29M)($378.50M)($357.20M)($346.77M)($343.45M)($327.98M)($324.23M)($316.56M)($315.44M)($307.41M)

Cash Flow

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Operating Cash Flow($14.39M)---$5.99M---$20.29M-
Investing Cash Flow----------
Financing Cash Flow$3.39M---($3.66M)---($5.13M)-
CapEx----------
Free Cash Flow----------

Ratios

MetricQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Profitability
Gross margin----------
Operating margin----------
EBITDA margin----------
Net margin----------
Free cash flow margin----------
FCF / Net income----------
R&D / Revenue----------
SG&A / Revenue----------
Effective tax rate----------
Return on assets-9.2%--0.7%1.6%-2.8%--0.3%1.8%-0.6%-
Return on equity-20.7%--1.3%2.8%-5.5%--0.5%3.5%-1.2%-
Return on invested capital----------
Liquidity
Current ratio----------
Quick ratio----------
Cash ratio----------
Leverage
Debt / Equity---------0.84
Debt / Assets---------0.46
Debt / EBITDA----------
Interest coverage----------
Equity multiplier2.262.111.981.751.921.871.961.901.911.84
Liabilities / Assets0.560.530.490.430.480.460.490.470.480.46
Efficiency
Asset turnover----------
Inventory turnover----------
Days sales outstanding----------
Days inventory outstanding----------
Days payable outstanding----------
Cash conversion cycle----------
Valuation
P / E35.4x-22.7x27.9x29.0x-28.3x22.6x28.8x-
P / B1.3x-0.8x1.0x1.2x-1.1x1.2x1.3x-
P / S----------
EV / EBITDA----------
Growth
Revenue growth (YoY)----------
Revenue CAGR (3y)----------
Revenue CAGR (5y)----------
Gross profit growth (YoY)----------
Operating income growth (YoY)----------
Net income growth (YoY)-214.3%--139.2%-16.6%-359.3%-92.2%-54.6%--
EPS growth (YoY)-44.4%--30.0%-38.5%-18.2%--9.1%0.0%-15.4%-
EPS CAGR (3y)-27.3%---------
EPS CAGR (5y)----------
FCF growth (YoY)----------
FCF CAGR (5y)----------
Book value growth (YoY)-17.2%-9.5%-0.3%3.3%3.1%6.2%-0.9%-6.2%-37.6%9.1%

Dividends

$0.42/share trailing 12 months · 0.0% YoY

Ex-datePer share
May 15, 2026$0.0350
Apr 16, 2026$0.0350
Mar 17, 2026$0.0350
Feb 13, 2026$0.0350
Jan 16, 2026$0.0350
Dec 17, 2025$0.0350
Nov 14, 2025$0.0350
Oct 17, 2025$0.0350
Sep 16, 2025$0.0350
Aug 15, 2025$0.0350
Jul 17, 2025$0.0350
Jun 16, 2025$0.0350
May 16, 2025$0.0350
Apr 16, 2025$0.0350
Mar 17, 2025$0.0350
Feb 14, 2025$0.0350
Jan 17, 2025$0.0350
Dec 17, 2024$0.0350
Nov 15, 2024$0.0350
Oct 17, 2024$0.0350
Sep 16, 2024$0.0350
Aug 16, 2024$0.0350
Jul 17, 2024$0.0350
Jun 14, 2024$0.0350